D
NeuroSense Therapeutics Ltd. NRSN
$1.14 -$0.0301-2.57% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 06/30/2024 09/30/2023
Revenue -- -- -- -- --
Total Other Revenue -- -- -- -- --
Total Revenue -- -- -- -- --
Cost of Revenue -- -- -- -- --
Gross Profit -- -- -- -- --
SG&A Expenses -- -- -- -- 3.65M
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses -- -- -- -- 9.75M
Operating Income -- -- -- -- -9.75M
Income Before Tax -- -- -- -- -8.67M
Income Tax Expenses -- -- -- -- --
Earnings from Continuing Operations -- -- -- -- -8.67
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -- -- -- -- -8.67M
EBIT -- -- -- -- -9.75M
EBITDA -- -- -- -- -9.73M
EPS Basic -- -- -- -- -0.71
Normalized Basic EPS -- -- -- -- -0.21
EPS Diluted -- -- -- -- -0.71
Normalized Diluted EPS -- -- -- -- -0.21
Average Basic Shares Outstanding -- -- -- -- 49.23M
Average Diluted Shares Outstanding -- -- -- -- 49.23M
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --